Development by UCLA-led research team works to keep blood sugar at normal levels
UCLA bioengineers and their colleagues have developed a new type of insulin that could help prevent hypoglycemia in people who use the drug to manage diabetes.
The treatment is being evaluated for potential clinical trials and, if successful, could change diabetes care. The study was published in the Proceedings of the National Academy of Sciences.
Insulin is a hormone naturally produced in the pancreas. It helps the body regulate glucose, which is consumed through food and provides the body with energy.
Diabetes occurs when a person’s body does not naturally produce insulin (Type 1 diabetes), or does not efficiently use the insulin that is produced (Type 2). In either case, a regular dosage of insulin is prescribed to manage the disease, which affects more than 400 million people worldwide.
Generally, people who need to use insulin monitor their blood sugar levels with a glucose meter or continuous glucose monitoring system and then calculate their insulin dose accordingly. In addition, a regular carbohydrate intake is important to keep the blood sugar levels normal. Both of these requirements are necessarily subject to human error, which can have potentially devastating consequences.
An overdose of insulin can cause hypoglycemia, when blood sugar is too low. That could lead to seizures, coma, and in extreme cases, death.
As a safety check, the UCLA-led team has developed a type of “smart” insulin, called i-insulin, that can prevent blood sugar levels from dipping too low.
Inside the body, insulin acts as a “key” to help glucose get into cells from the bloodstream. When insulin attaches to a cell’s surface, it activates a protein inside the cell, called glucose transporter, which then makes its way to the cell’s surface. This molecule then brings the surrounding glucose from the blood into the cell.
The research team added an additional molecule to insulin to create the new smart insulin. This added molecule, called a glucose transporter inhibitor, chemically blocks the glucose transporter molecule that has come to the surface. Its presence doesn’t block all glucose from entering, nor does it permanently block the transporter molecules. Instead, it’s part of a dynamic process that depends on how many inhibitor and glucose molecules are present.
“Our new i-insulin works like a ‘smart’ key,” said the study’s principal investigator Zhen Gu, a professor of bioengineering at the UCLA Samueli School of Engineering. “The insulin lets glucose get into the cell, but the added inhibitor molecule prevents too much from going in when blood sugar is normal. This keeps blood sugar at normal levels and reduces the risk of hypoglycemia.”
“This i-insulin can also rapidly respond to high glucose levels,” added Jinqiang Wang, the study’s co-lead author and a postdoctoral researcher in Gu’s research group. “For example, after a meal, when glucose levels climb, the insulin level in the bloodstream also quickly increases, which helps normalize the glucose level.”
The UCLA-led research team tested the smart insulin on mice with Type 1 diabetes. The i-insulin controlled glucose levels within the normal range for up to 10 hours after a first injection. A second injection three hours later extended the protection from hypoglycemia.
“The next step is to further evaluate the long-term biocompatibility of the modified insulin system in an animal model before determining whether to move to clinical trials,” said co-author Dr. John Buse, a professor and director of the Diabetes Care Center at the University of North Carolina School of Medicine. “The vision, if realized, would be one of the most exciting advances in diabetes care.”
“The new insulin has the potential to be optimized for response times and how long it could last in the body before another dose would be required,” Gu said. “And it could be delivered in other methods, such as a skin patch with tiny needles, or in pills.”
The Latest on: Diabetes
via Google News
The Latest on: Diabetes
- Guavas For Diabetes: 5 Reasons Why You Must Eat More Guavas To Manage Blood Sugaron October 16, 2019 at 9:32 pm
Guavas unique nutrient composition makes it an excellent food for a diabetes diet. The light green coloured fruit with soft, seeded pulp appears mostly in the winter season.
- Type 2 diabetes: Five snacks to help you manage blood sugar levelson October 16, 2019 at 8:09 pm
Type 2 diabetes means a person’s pancreas doesn’t produce enough insulin to regulate blood sugar levels. Over time, rising blood sugars can raise a person’s risk of developing deadly complications ...
- Diabetes: A next-generation therapy soon available?on October 16, 2019 at 11:59 am
Insulin is normally produced by pancreatic beta cells. In many people with diabetes, pancreatic cells are not functional, causing a chronic and potentially fatal insulin deficiency that can only be ...
- Habenular TCF7L2 links nicotine addiction to diabeteson October 16, 2019 at 10:31 am
Diabetes is far more prevalent in smokers than non-smokers, but the underlying mechanisms of vulnerability are unknown. Here we show that the diabetes-associated gene Tcf7l2 is densely expressed in ...
- Brain-to-pancreas signalling axis links nicotine and diabeteson October 16, 2019 at 10:30 am
The discovery of a signalling axis that connects nicotine responses in the brain with glucose metabolism by the pancreas sheds light on why cigarette smoking increases the risk of diabetes. Giuseppe ...
- Smoke signals: Study shows path linking nicotine addiction to increased risk for diabeteson October 16, 2019 at 10:03 am
Researchers from the Icahn School of Medicine at Mount Sinai have discovered a circuit in rats that links cigarette smoking and the risk of developing type 2 diabetes, according to a study featured on ...
- Does the rotavirus vaccine prevent type 1 diabetes?on October 16, 2019 at 8:06 am
Healthline Media, Inc. would like to process and share personal data (e.g., mobile ad id) and data about your use of our site (e.g., content interests) with our third party partners (see a current ...
- Black patients with diabetes have higher 30-day readmission rateson October 15, 2019 at 1:00 pm
(HealthDay)—Black patients with diabetes have a significantly higher risk for 30-day readmission compared with other racial/ethnic groups, according to a study published online Oct. 11 in JAMA Network ...
- Prevalence of Dental Caries in Children and Adolescents With Type 1 Diabeteson October 15, 2019 at 10:47 am
Background: Dental caries and type 1 diabetes are responsible for a large burden of global disease; however, the exact prevalence of dental caries among children and adolescents with type 1 diabetes ...
- Endocrine Society Report Addresses Post-Meal Glucose in Diabeteson October 15, 2019 at 8:57 am
A new report from the Endocrine Society highlights the challenge of postprandial glucose management for people with insulin-requiring diabetes, providing some recommendations but also pointing out the ...
via Bing News